Live Breaking News & Updates on Dermatology physician assistants

Stay informed with the latest breaking news from Dermatology physician assistants on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Dermatology physician assistants and stay connected to the pulse of your community

Noninvasive skin cancer treatment now available in Gallatin Co.

There’s a new, noninvasive way to treat nonmelanoma skin cancer in Gallatin County at SkinCare MT.It’s called image-guided superficial radiation therapy, also k

United-states , Montana , Gallatin-county , Salt-lake-city , Utah , American , Americans , Christian-appel , Aaron-bruce , American-academy-of-dermatology , American-academy , Salt-lake

IL-23 inhibitors may have a lower risk of paradoxical eczema in comparison to other biologics

1. Interleukin-23 inhibitors had a lower risk of developing paradoxical eczema when treated for plaque psoriasis compared to TNF inhibitors, IL-17 inhibitors and IL-12/23 2. Clinical features associated with increased paradoxical eczema risks included increasing age, history of atopic dermatitis, and history of hay fever. The risk was also lower in males. Evidence Rating Level:

Ireland , United-kingdom , British-association-of-dermatologists-biologics , Rating-level , British-association , Dermatologists-biologics , Immunomodulators-register , Atopic-dermatitis , Eczema , Il-23-inhibitor , Plaque-psoriasis

Signs your rash needs medical attention

Rashes take many forms, may spread across the body, and affect people of all ages. To the untrained eye, rashes may look alike, and while some are treatable wit

Youtube , National-healthy-skin-month , Mallory-abate , Baton-rouge , Newswise , Ad-american-academy-of-dermatology-rash-skin-derm-medical-attention-board-certified-dermatologist-condition-your-knows , Dermatology , Ealthcare , Ublic-health , Merican-academy-of-dermatology ,

RI doctors simplify medical consent forms through AI

Rhode Island doctors are working to make medical forms easier for patients through AI."These forms can be very long and tedious," said Dr. Rohaid Ali, a neuros

Rhode-island-hospital , Rhode-island , United-states , Fatima-mirza , Rohaid-ali , Lifespan-rhode-island , Brown-dermatology , Hartford-healthcare , Hartford-healthcare-corporation , Health-medical-pharma , Computational-neuroscience

Martina J. Porter, MD: Adverse Events, Future Research on Lutikizumab for HS

In this segment of Porter’s interview, she delves further into the phase 2 findings on lutikizumab and discusses any adverse events and future research.

Martinaj-porter , Harvard-medical-school , Hs , Hidradenitis-suppurativa , Lutikizumab , Dermatology , Porter ,

I Let ChatGPT Decide My Skin-Care Routine for a Month — Here's How It Went

One beauty writer devised an experiment where she'd get a skin-care regimen from ChatGPT, use it for a month, and consult with dermatologists along the way to see their perception of how things were going. Did she achieve the best skin of her life? Not no.

Bill-gates , Dyson-airwrap , Microsoft , Aesthete-genius , Ulta-beauty , Feature , Technology , Artificial-intelligence , Dermatology , Skin-care , Shopping ,

Active Vitiligo Considered a Risk Factor for Vitiligo Progression Following COVID-19 Vaccination

These data indicate the necessity of further research to clarify any associations between COVID-19 infection, the virus’s associated vaccines, and progression of vitiligo.

Beijing , China , Xiaoyi-shi , Shanxi , Peking , Chinese , University-people-hospital-department , University-people-hospital , Peking-university , Peking-university-people , Vitiligo

Positive Results Seen in Orismilast Treatment of Patients with HS

Twice-daily PDE4-inhibition using 10–40 mg of orismilast showed promise though further studies may be necessary to validate these findings.

Saunte , Hovedstaden , Denmark , Roskilde , Sjæand , France , French , Hidradenitis-suppurativa , Dermatol-venereol , University-hospital-of-zealand , International-hs-severity , Zealand-university-hospital

Dermatology Month in Review: December 2023

The December 2023 month in review for dermatology covers major stories regarding a new FDA approval, several new treatment findings, and news on attitudes toward those with acne.

Bern , Switzerland , Arcutis-biotherapeutics , Raj-chovatiya , Drug-administration , Ludwig-maximilian-university-of-munich , Copayment-beneficiaries-program , University-of-bern , Dermatology-stories , Ludwig-maximilian-university , Eczema-area , Severity-index

Around Half of Erythema Nodosum Patients Report Chronic, Recurrent Disease

These data expand upon the limited literature available around the world regarding this inflammatory skin disorder.

Jillt-shah , Pearson , York-university-langone-health , New-york-university-langone-health , New-york-university , Erythema-nodosum , En , Chronic , Skin , Dermatology ,

Live Breaking News & Updates on Dermatology physician assistants

In this segment of Porter’s interview, she delves further into the phase 2 findings on lutikizumab and discusses any adverse events and future research.Martinaj-porter , Harvard-medical-school , Hs , Hidradenitis-suppurativa , Lutikizumab , Dermatology , Porter ,

These data expand upon the limited literature available around the world regarding this inflammatory skin disorder.Jillt-shah , Pearson , York-university-langone-health , New-york-university-langone-health , New-york-university , Erythema-nodosum , En , Chronic , Skin , Dermatology ,

In this segment of Porter’s interview, she delves further into the phase 2 findings on lutikizumab and discusses any adverse events and future research.

Martinaj-porter , Harvard-medical-school , Hs , Hidradenitis-suppurativa , Lutikizumab , Dermatology , Porter ,

These data expand upon the limited literature available around the world regarding this inflammatory skin disorder.

Jillt-shah , Pearson , York-university-langone-health , New-york-university-langone-health , New-york-university , Erythema-nodosum , En , Chronic , Skin , Dermatology ,